Stroke and bleeding risk evaluation in atrial fibrillation: results of the European Heart Rhythm Association survey

被引：7

作者：

Larsen, Torben Bjerregaard ^{[1
,2
]}

Potpara, Tatjana ^{[3
]}

Dagres, Nikolaos ^{[4
]}

Pison, Laurent ^{[5
]}

Estner, Heidi ^{[6
]}

Blomstrom-Lundqvist, Carina ^{[7
]}

机构：

[1] Aalborg Univ Hosp, Aalborg AF Study Grp, Dept Cardiol, DK-9000 Aalborg, Denmark

[2] Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, DK-9220 Aalborg, Denmark

[3] Univ Belgrade, Sch Med, Cardiol Clin, Clin Ctr Serbia, Belgrade 11000, Serbia

[4] Univ Athens, Dept Cardiol 2, Attikon Univ Hosp, Athens 12462, Greece

[5] Maastricht Univ, Med Ctr, Dept Cardiol, Cardiovasc Res Inst, Maastricht, Netherlands

[6] Univ Munich, Med Klin, D-81377 Munich, Germany

[7] Uppsala Univ, Inst Med Sci, Dept Cardiol, S-75105 Uppsala, Sweden

来源：

EUROPACE | 2014年 / 16卷 / 05期

关键词：

Atrial fibrillation; Anticoagulation; Stroke; Bleeding; Risk stratification; CHADS(2); CHA(2)DS(2)-VASc; HAS-BLED; New oral anticoagulants; Warfarin; EHRA survey; EP wire; Guidelines; VITAMIN-K ANTAGONISM; ORAL ANTICOAGULANTS; PREDICTING STROKE; RENAL DYSFUNCTION; EMBOLISM TRIAL; PREVENTION; STRATIFICATION; R(2)CHADS(2); VALIDATION; GUIDELINES;

D O I：

10.1093/europace/euu089

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The aim of this European Heart Rhythm Association (EHRA) survey was to assess clinical practice in relation to stroke and bleeding risk evaluation in atrial fibrillation, particularly regarding the use of risk evaluation schemes, among members of the EHRA electrophysiology (EP) research network. In this EP Wire survey, we have provided some insights into current practice in Europe for the use of these risk assessment schemes. There were some obvious practice differences. However, reassuring information on current practice in Europe was evident, but more focus on renal function is warranted, especially facing the fact that novel oral anticoagulants are used for antithrombotic therapy.

引用

页码：698 / 702

页数：5

共 16 条

[1]

[Anonymous], 2007, NEUROLOGY, V69, P546

[2]

Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/eurheartj/ehs253, 10.1093/europace/eus305]

[3]

Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]

[4] Validation of clinical classification schemes for predicting stroke - Results from the national registry of Atrial Fibrillation [J].

Gage, BF ;

Waterman, AD ;

Shannon, W ;

Boechler, M ;

Rich, MW ;

Radford, MJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (22) :2864-2870

[5] Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation [J].

Hart, Robert G. ;

Pearce, Lesly A. ;

Halperin, Jonathan L. ;

Hylek, Elaine M. ;

Albers, Gregory W. ;

Anderson, David C. ;

Connolly, Stuart J. ;

Friday, Gary H. ;

Gage, Brian F. ;

Go, Alan S. ;

Goldstein, Larry B. ;

Gronseth, Gary ;

Lip, Gregory Y. H. ;

Sherman, David G. ;

Singer, Daniel E. ;

van Walraven, Carl .

STROKE, 2008, 39 (06) :1901-1910

[6] Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation [J].

Hart, Robert G. ;

Pearce, Lesly A. ;

Aguilar, Maria I. .

ANNALS OF INTERNAL MEDICINE, 2007, 146 (12) :857-867

[7] European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation [J].

Heidbuchel, Hein ;

Verhamme, Peter ;

Alings, Marco ;

Antz, Matthias ;

Hacke, Werner ;

Oldgren, Jonas ;

Sinnaeve, Peter ;

Camm, A. John ;

Kirchhof, Paulus .

EUROPACE, 2013, 15 (05) :625-651

[8] Renal Dysfunction, Stroke Risk Scores (CHADS2, CHA2DS2-VASc, and R2CHADS2), and the Risk of Thromboembolic Events After Catheter Ablation of Atrial Fibrillation The Leipzig Heart Center AF Ablation Registry [J].

Kornej, Jelena ;

Hindricks, Gerhard ;

Kosiuk, Jedrzej ;

Arya, Arash ;

Sommer, Philipp ;

Husser, Daniela ;

Rolf, Sascha ;

Richter, Sergio ;

Piorkowski, Christopher ;

Gaspar, Thomas ;

Lip, Gregory Y. H. ;

Bollmann, Andreas .

CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY, 2013, 6 (05) :868-874

[9] Atrial fibrillation and stroke prevention [J].

Lip, Gregory Y. H. ;

Lim, Hoong Sem .

LANCET NEUROLOGY, 2007, 6 (11) :981-993

[10] Novel oral anticoagulants for stroke prevention in atrial fibrillation: results of the European Heart Rhythm Association survey [J].

Lip, Gregory Y. H. ;

Bongiorni, Maria Grazia ;

Dobreanu, Dan ;

Lewalter, Thorsten ;

Hastrup Svendsen, Jesper ;

Blomstrom-Lundqvist, Carina .

EUROPACE, 2013, 15 (10) :1526-1532

← 1 2 →